Rong-Ping Guo
Overview
Explore the profile of Rong-Ping Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
3298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou Y, Zhang T, Ma L, Jiang Y, Han X, Di T, et al.
Acad Radiol
. 2025 Feb;
PMID: 40016001
Rationale And Objectives: Large hepatocellular carcinoma (HCC) exhibits heterogeneous morphologies and varied responses to treatment. We evaluated outcomes of patients with different large HCC classifications receiving surgical resection (SR) or...
2.
Lin Y, Li S, Yang X, Guo R, Huang Y, Bai K, et al.
J Cancer Res Clin Oncol
. 2024 Jun;
150(6):309.
PMID: 38890157
Purpose: Limited treatment options exist for unresectable intrahepatic cholangiocarcinoma (ICC), with systemic chemotherapy (SC) serving as the primary approach. This study aimed to assess the effectiveness of first-line hepatic arterial...
3.
Ling Y, Liu M, Yin Y, Zhou Z, Chen J, Wei W, et al.
Signal Transduct Target Ther
. 2023 Jun;
8(1):244.
PMID: 37349321
No abstract available.
4.
Li S, Mei J, Cheng Y, Li Q, Wang Q, Fang C, et al.
J Clin Oncol
. 2022 Dec;
41(10):1898-1908.
PMID: 36525610
Purpose: To report the efficacy and safety of postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and oxaliplatin (FOLFOX) in hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI). Patients...
5.
Deng M, Lin J, Zhao R, Li S, Lin W, Zou J, et al.
BMC Cancer
. 2021 Dec;
21(1):1347.
PMID: 34923955
Background: The accuracy of existing biomarkers for predicting the prognosis of hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that can accurately predict the prognosis of...
6.
Xu Y, Lai Z, He M, Bu X, Chen H, Zhou Y, et al.
Technol Cancer Res Treat
. 2021 Dec;
20:15330338211063848.
PMID: 34898313
Immunotherapy combined with chemotherapy have synergistic effects in multiple malignancies. We aimed to compare the efficacy and safety of toripalimab plus hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and...
7.
Deng M, Li S, Guo R
Am Surg
. 2021 Nov;
89(5):1966-1973.
PMID: 34743609
Image-guided local thermal ablation (LTA) plays an important role in the treatment of hepatocellular carcinoma (HCC), especially in patients with HCC who are not suitable for hepatectomy. Radiofrequency ablation (RFA)...
8.
Li Q, He M, Chen H, Fang W, Zhou Y, Xu L, et al.
J Clin Oncol
. 2021 Oct;
40(2):150-160.
PMID: 34648352
Purpose: In a previous phase II trial, hepatic arterial infusion chemotherapy (HAIC) with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX) yielded higher treatment responses than transarterial chemoembolization (TACE) in large unresectable...
9.
Lin W, Xing K, Fu J, Ling Y, Li S, Yu W, et al.
JAMA Netw Open
. 2021 Sep;
4(9):e2125055.
PMID: 34515782
Importance: Because of tumor heterogeneity, traditional clinical variables remain insufficient to predict recurrence, which impairs long-term survival among patients undergoing radical hepatectomy for hepatocellular carcinoma (HCC). Vessels encapsulating tumor clusters...
10.
Deng M, Fang L, Li S, Zhao R, Mei J, Zou J, et al.
Mutagenesis
. 2021 Sep;
36(5):369-379.
PMID: 34467992
Hepatocellular carcinoma (HCC) is still one of the most common malignancies worldwide. The accuracy of biomarkers for predicting the prognosis of HCC and the therapeutic effect is not satisfactory. N6-methyladenosine...